English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Meeting Abstract

Systematic organization of cortical thickness co-alterations in substance use disorders

MPS-Authors
/persons/resource/persons71665

Valk,  Sofie L.       
Otto Hahn Group Cognitive Neurogenetics, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons270685

Hettwer,  Meike
Otto Hahn Group Cognitive Neurogenetics, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Valk, S. L., Georgiadis, F., Hettwer, M., Thomopoulos, S., Thompson, P., Mackey, S., et al. (2024). Systematic organization of cortical thickness co-alterations in substance use disorders. Biological Psychiatry, 95(Suppl.): S106. doi:10.1016/j.biopsych.2024.02.253.


Cite as: https://hdl.handle.net/21.11116/0000-000F-3E5B-7
Abstract
Background

Previous research has demonstrated systematic structural alterations in neuropsychiatric disorders, linked to the human connectome's intrinsic organization. However, it remains unclear if similar coordinated co-alteration effects extend to substance use disorders (SUDs). Here, we examined substance use co-alteration networks (SUDcov) to uncover macroscale principles of illness and substance-use effects across the cortex.
Methods

We derived maps of case-control differences in cortical thickness from 2,847 patients with six substance use disorders (alcohol, methamphetamines, cocaine, opioids, cannabis, nicotine) and 1,951 non-affected individuals from the ENIGMA Addiction Working Group. We investigated substance use co-alteration networks via inter-regional SUD association with cortical thickness and performed probed systematic co-organisation with covariance and neuropsychiatric co-alterations using hub, epicenter and diffusion map embedding modeling.
Results

SUDcov hubs followed normative functional (r=0.527, pspin < 0.05) and structural (r=0.314, pspin < 0.05) connectivity patterns, linking to epicenters. SUDcov and cortical thickness covariance patterns overlapped, apart from inferior temporal areas and medial orbitofrontal cortex (mOFC). The primary gradient of SUDcov differentiated OFC/cingulate from the rest of the cortex and mirrored the second covariance and neuropsychiatric co-alteration gradient (pspin < 0.05). The second SUDcov gradient differentiated parietal and OFC areas from the rest of the cortex. Hierarchical clustering of SUD and neuropsychiatric co-alteration patterns further underlined this differentiation.
Conclusions

Substance use co-alteration networks are organized in a network-like fashion. These patterns underscore the differentiation between paralimbic and other regions of the cerebral cortex by SUDs co-alterations. We observed a differentiation between SUD and neuropsychiatric co-alteration networks, possibly related to co-morbidity and neurodevelopmental factors.